Potts M, Denny C
School of Public Health, University of California, Berkeley, USA.
Drug Saf. 1995 Dec;13(6):333-7. doi: 10.2165/00002018-199513060-00002.
The idea of making oral contraceptives available without prescription has a long history, and has been recently revived in the US and the UK. High dose oral contraceptives have generally been replaced by low dose formulations and, subsequently, most cardiovascular risks have been reduced and a protection against ovarian and uterine cancers has been consistently demonstrated. Oral contraceptive compliance, however, continues to be a problem, but there is no reason to assume that wise practice would be any more or less if oral contraceptives were available over-the-counter (OTC). Some countries have introduced alternatives to prescription-only oral contraceptives, whereby nurses, midwives, social workers and/or pharmacists are incorporated into the distribution process. This article concludes that the balance of risks and benefits is in favour of OTC access for oral contraceptives.
非处方提供口服避孕药的想法由来已久,最近在美国和英国又重新兴起。高剂量口服避孕药通常已被低剂量配方所取代,随后,大多数心血管风险降低,并且一直证明对卵巢癌和子宫癌有预防作用。然而,口服避孕药的依从性仍然是个问题,但没有理由认为,如果口服避孕药可以非处方购买,明智的做法会有所增减。一些国家已经推出了仅凭处方购买的口服避孕药的替代方案,将护士、助产士、社会工作者和/或药剂师纳入了分发过程。本文的结论是,风险和益处的权衡有利于口服避孕药的非处方获取。